Core Insights - CareCloud, Inc. experienced a stock price increase of approximately 70% in Q2 2025, positioning it among the top gainers in the Russell Microcap Index [1][2] - The company was officially added to the Russell Microcap Index effective June 30, 2025, reflecting its growing visibility and investor confidence [2] - Co-CEO Stephen Snyder highlighted the company's focus on AI innovation, targeted acquisitions, and a strengthened capital structure as key drivers for long-term growth [3] Company Performance - CareCloud's disciplined execution is expected to lead to continued momentum into the second half of 2025 [4] - The company launched a new AI Center of Excellence and resumed M&A activity targeting high-potential verticals [9] - CareCloud completed the conversion of 3.5 million Series A Preferred shares into Common Stock and ended the quarter with over $10 million in cash [9] Company Overview - CareCloud is a leading provider of healthcare technology solutions, offering a comprehensive suite of revenue cycle, practice management, and patient engagement solutions supported by AI technologies [5]

Core Insights - CareCloud, Inc. has been added to the Russell Microcap® Index, effective June 30, 2025, highlighting its growing recognition in the healthcare technology sector [1][3] - The company's common stock price increased by approximately 70% during Q2 2025, driven by key developments including the launch of an AI Center of Excellence and a strong cash position of around $10 million [2] Company Developments - The launch of CareCloud's AI Center of Excellence is a significant milestone aimed at enhancing its technological capabilities [2] - The company resumed acquisition activities in targeted growth areas, indicating a strategic focus on expansion [2] - Approximately 3.5 million shares of Series A Preferred Stock were converted into Common Stock on March 6, 2025, reflecting a shift in capital structure [2] Financial Performance - CareCloud reported a strong cash position of approximately $10 million at the end of Q2 2025, which supports its operational and strategic initiatives [2] - The inclusion in the Russell Microcap Index serves as a benchmark for performance in the U.S. small-cap equity market, potentially attracting more institutional investors [3]

Core Points - CareCloud has surpassed the accelerated filer threshold with a public float of $85.1 million as of June 30, 2025, triggering new compliance requirements under SEC regulations [1] - The achievement is seen as a validation of CareCloud's growth trajectory and investor confidence, with a commitment to compliance and corporate governance emphasized by the Co-CEO [2] - The current audit firm cannot perform the required ICFR attestation, necessitating a change in auditors to ensure compliance [2] - CareCloud has initiated a process to engage a new audit firm capable of fulfilling the necessary services for fiscal year 2025 [3] Company Overview - CareCloud specializes in AI-driven healthcare technology solutions, helping over 40,000 providers enhance patient care while reducing administrative burdens and operating costs [4]

Core Viewpoint - CareCloud, Inc. may need to engage a new independent registered public accounting firm if an ICFR auditor attestation is required for fiscal year 2025 due to its current audit firm's inability to perform the required services [1][2]. Group 1: Audit and Compliance - The current audit firm has indicated it lacks the capacity to perform an ICFR attestation, which is necessary if CareCloud's public float exceeds $75 million [2]. - The determination of whether an ICFR attestation is required will be based on CareCloud's public float as of June 30, 2025, with a threshold of $75 million for classification as an accelerated filer [3]. - CareCloud plans to provide an update on July 1, 2025, regarding its public float and any implications for its audit arrangements [3]. Group 2: Company Overview - CareCloud is a leader in AI-driven healthcare technology solutions, offering services that enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4]. - The company serves over 40,000 providers, focusing on reducing administrative burdens and operating costs through its suite of solutions, including revenue cycle management, practice management, electronic health records, and digital health [4].

© CareCloud, Inc. 2025 DRIVING NEXT-GEN HEALTHCARE WITH GENERATIVE AI SOLUTIONS Nasdaq Global Market: CCLD, CCLDO Investor Presentation May 2025 A healthcare technology company with 25 years of experience, delivering AI-driven, end-to-end solutions that power real- world clinical and financial transformation. Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of o ...

Core Insights - CareCloud, Inc. is participating in the "2025 Virtual Tech Conference" to discuss the impact of AI on healthcare delivery [1][2] - The conference will highlight how emerging growth companies are utilizing transformative technologies like AI and Quantum Computing for long-term success [3] Company Overview - CareCloud specializes in AI-driven healthcare technology solutions, aiming to enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4] - The company serves over 40,000 providers, focusing on reducing administrative burdens and operating costs while improving patient care [4] Conference Details - The Healthcare IT Panel featuring CareCloud is scheduled for June 3, 2025, at 11:00 a.m. EDT [1] - Participants must register as M-Vest members to attend the conference and view CareCloud's presentation [3]

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected three board members and approved executive compensation and the appointment of an accounting firm [1][2][3] - The re-elected board members include Anne Busquet, Bill Korn, and Lawrence Sharnak, all of whom have extensive experience in executive roles [2] - The shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Company Overview - CareCloud is a leader in healthcare technology solutions, providing services that enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4] - The Company serves over 40,000 providers, helping them reduce administrative burdens and operating costs while improving patient care [4]

Core Points - CareCloud, Inc. held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders re-elected Anne Busquet, Bill Korn, and Lawrence Sharnak to the Board for another two-year term [1][2] - Shareholders approved the advisory compensation for the Company's named executive officers as disclosed in the 2025 Proxy Statement [1][7] - Rosenberg Rich Baker Berman, P.A. was appointed as the independent registered public accounting firm for the year ending December 31, 2025 [1][7] Group 1 - Anne Busquet has over 30 years of executive experience with American Express and Interactive Corp [2] - Bill Korn served as Chief Financial Officer for 10 years before retiring in October 2023 [2] - Lawrence Sharnak held various senior leadership roles at American Express for more than 30 years [2] Group 2 - CareCloud provides technology-enabled solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [4] - The Company serves over 40,000 providers, helping them improve patient care while reducing administrative burdens and operating costs [4]

Core Insights - CareCloud has been named Maxim Group's "Top Healthcare IT Pick for 2025" due to its transformative AI strategy and strong financial performance [1][2][3] - The company is trading at a 2026 EV/EBITDA multiple of 5.0x, significantly lower than the peer group average of 12.5x, indicating an attractive investment opportunity [2] - CareCloud's Q1 2025 performance showed a 52% year-over-year growth in adjusted EBITDA, highlighting its operational momentum [4] Company Strategy and Developments - CareCloud's AI Center of Excellence was launched with an initial team of over 50 AI professionals, aiming to scale to 500 by year-end, positioning the company as a leader in applied AI within healthcare [4] - The company emphasizes that AI is integrated into its core operations, enhancing documentation, revenue cycle management, patient engagement, and analytics [5] - CareCloud's AI suite, including tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, is highlighted as a key differentiator in the market [3] Financial Performance - The company has resumed preferred dividends and is returning to M&A-driven growth, contributing to its positive outlook [3] - CareCloud's commitment to delivering cost-effective technology aims to improve healthcare outcomes and operational efficiency for its clients [5] - More than 40,000 providers rely on CareCloud's solutions to enhance patient care while reducing administrative burdens [6]

Financial Performance - For the three months ended March 31, 2025, net revenue was $27,632,000, an increase of 6.4% from $25,962,000 in the same period of 2024[161] - Adjusted EBITDA for the same period was $5,595,000, up 51.8% from $3,687,000 in 2024[161] - GAAP net income for Q1 2025 was $1,948,000 compared to a loss of $241,000 in Q1 2024[161] - The adjusted operating margin improved to 8.5% in Q1 2025 from 2.3% in Q1 2024[161] - Non-GAAP adjusted net income for Q1 2025 was $2,290,000, compared to $220,000 in Q1 2024[164] - The GAAP operating margin for Q1 2025 was 7.3%, significantly higher than 0.5% in Q1 2024[161] - Non-GAAP adjusted earnings per share for Q1 2025 was $0.05, compared to $0.01 in Q1 2024[164] - Net income for the three months ended March 31, 2025, was $1.96 million, compared to a net loss of $0.23 million in the same period of 2024[179] - The company recorded net income of $7.9 million for fiscal year 2024, a significant improvement from a net loss of $48.7 million in fiscal year 2023[195] Revenue Composition - Revenue for the three months ended March 31, 2025, was $27.6 million, an increase of $1.7 million or 6% from $25.9 million in the same period of 2024[180] - Technology-enabled business solutions accounted for approximately 64% of total revenue for the three months ended March 31, 2025[167] Expenses - Direct operating costs increased by $287,000 or 2% to $15.5 million for the three months ended March 31, 2025, compared to $15.2 million in 2024[182] - Selling and marketing expenses decreased by $639,000 or 36% to $1.1 million for the three months ended March 31, 2025[183] - General and administrative expenses increased by $611,000 or 16% to $4.3 million for the three months ended March 31, 2025[184] - Research and development expenses increased by $322,000 or 35% to $1.2 million for the three months ended March 31, 2025[185] Cash Flow and Capital Expenditures - As of March 31, 2025, the company had total cash of $6.8 million and net working capital of $11.7 million[194] - Net cash provided by operating activities increased to $5.1 million for the three months ended March 31, 2025, up 26% from $4.1 million in the same period of 2024[199] - Net cash used in investing activities decreased to $1.5 million in Q1 2025 from $1.9 million in Q1 2024, reflecting a 19% reduction[201] - Net cash used in financing activities increased to $1.9 million in Q1 2025, compared to $1.4 million in Q1 2024, representing a 41% increase[202] - Capital expenditures for Q1 2025 were $624,000, up from $298,000 in Q1 2024, primarily for computer equipment and leasehold improvements[201] - Software development costs capitalized were $846,000 in Q1 2025, down from $1.6 million in Q1 2024[201] Operational Insights - The company served approximately 40,000 providers as of March 31, 2025, maintaining the same level as in 2024[166] - The company has approximately 290 experienced health industry experts in the U.S. and a specialized offshore workforce of about 3,400[154] - Offshore operations in Pakistan and Sri Lanka accounted for approximately 17% and 15% of total expenses for Q1 2025 and 2024, respectively[156] Financial Strategy and Outlook - Management expects to continue enhancing liquidity and financial position over the next twelve months[196] - The company maintained a revolving line of credit with an unused borrowing base of $10 million as of March 31, 2025[198] - The company has been able to monitor and mitigate the impact of inflation through pricing strategies and productivity improvements[197] - The interest rate on the company's line of credit is based on the prime rate, which has shown slight fluctuations in 2023 and 2024[197]